Low direct cytotoxicity of loxoprofen on gastric mucosal cells

Naoki Yamakawa, Shintaro Suemasu, Ayumi Kimoto, Yasuhiro Arai, Tomoaki Ishihara, Kazumi Yokomizo, Yoshinari Okamoto, Masami Otsuka, Ken Ichiro Tanaka, Tohru Mizushima

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Pro-drugs of non-steroidal anti-inflammatory drugs (NSAIDs), such as loxoprofen are widely used for clinical purposes because they are not so harmful to the gastrointestinal mucosa. We recently showed that NSAIDs such as indomethacin and celecoxib have direct cytotoxicity (ability to induce necrosis and apoptosis in gastric mucosal cells) due to their membrane permeabilizing activities, which is involved in NSAID-induced gastric lesions. We show here that under conditions where indomethacin and celecoxib clearly induce necrosis and apoptosis, loxoprofen and its active metabolite loxoprofen-OH, do not have such effects in primary culture of guinea pig gastric mucosal cells. Loxoprofen and loxoprofen-OH induced apoptosis more effectively in cultured human gastric cancer cells than in the primary culture. Loxoprofen and loxoprofen-OH exhibited much lower membrane permeabilizing activities than did indomethacin and celecoxib. We thus consider that the low direct cytotoxicity of loxoprofen observed in vitro is involved in its relative safety on production of gastric lesions in clinical situation.

Original languageEnglish
Pages (from-to)398-403
Number of pages6
JournalBiological and Pharmaceutical Bulletin
Volume33
Issue number3
DOIs
Publication statusPublished - 2010
Externally publishedYes

Fingerprint

Celecoxib
Stomach
Indomethacin
Anti-Inflammatory Agents
Apoptosis
Necrosis
Gastrointestinal Agents
Primary Cell Culture
Membranes
loxoprofen
Prodrugs
Pharmaceutical Preparations
Stomach Neoplasms
Guinea Pigs
Mucous Membrane
Safety

Keywords

  • Gastric lesion
  • Gastric mucosal cell
  • Loxoprofen
  • Membrane permeabilization

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Pharmacology
  • Medicine(all)

Cite this

Yamakawa, N., Suemasu, S., Kimoto, A., Arai, Y., Ishihara, T., Yokomizo, K., ... Mizushima, T. (2010). Low direct cytotoxicity of loxoprofen on gastric mucosal cells. Biological and Pharmaceutical Bulletin, 33(3), 398-403. https://doi.org/10.1248/bpb.33.398

Low direct cytotoxicity of loxoprofen on gastric mucosal cells. / Yamakawa, Naoki; Suemasu, Shintaro; Kimoto, Ayumi; Arai, Yasuhiro; Ishihara, Tomoaki; Yokomizo, Kazumi; Okamoto, Yoshinari; Otsuka, Masami; Tanaka, Ken Ichiro; Mizushima, Tohru.

In: Biological and Pharmaceutical Bulletin, Vol. 33, No. 3, 2010, p. 398-403.

Research output: Contribution to journalArticle

Yamakawa, N, Suemasu, S, Kimoto, A, Arai, Y, Ishihara, T, Yokomizo, K, Okamoto, Y, Otsuka, M, Tanaka, KI & Mizushima, T 2010, 'Low direct cytotoxicity of loxoprofen on gastric mucosal cells', Biological and Pharmaceutical Bulletin, vol. 33, no. 3, pp. 398-403. https://doi.org/10.1248/bpb.33.398
Yamakawa N, Suemasu S, Kimoto A, Arai Y, Ishihara T, Yokomizo K et al. Low direct cytotoxicity of loxoprofen on gastric mucosal cells. Biological and Pharmaceutical Bulletin. 2010;33(3):398-403. https://doi.org/10.1248/bpb.33.398
Yamakawa, Naoki ; Suemasu, Shintaro ; Kimoto, Ayumi ; Arai, Yasuhiro ; Ishihara, Tomoaki ; Yokomizo, Kazumi ; Okamoto, Yoshinari ; Otsuka, Masami ; Tanaka, Ken Ichiro ; Mizushima, Tohru. / Low direct cytotoxicity of loxoprofen on gastric mucosal cells. In: Biological and Pharmaceutical Bulletin. 2010 ; Vol. 33, No. 3. pp. 398-403.
@article{7c551692135c482888b51fc85bd1b126,
title = "Low direct cytotoxicity of loxoprofen on gastric mucosal cells",
abstract = "Pro-drugs of non-steroidal anti-inflammatory drugs (NSAIDs), such as loxoprofen are widely used for clinical purposes because they are not so harmful to the gastrointestinal mucosa. We recently showed that NSAIDs such as indomethacin and celecoxib have direct cytotoxicity (ability to induce necrosis and apoptosis in gastric mucosal cells) due to their membrane permeabilizing activities, which is involved in NSAID-induced gastric lesions. We show here that under conditions where indomethacin and celecoxib clearly induce necrosis and apoptosis, loxoprofen and its active metabolite loxoprofen-OH, do not have such effects in primary culture of guinea pig gastric mucosal cells. Loxoprofen and loxoprofen-OH induced apoptosis more effectively in cultured human gastric cancer cells than in the primary culture. Loxoprofen and loxoprofen-OH exhibited much lower membrane permeabilizing activities than did indomethacin and celecoxib. We thus consider that the low direct cytotoxicity of loxoprofen observed in vitro is involved in its relative safety on production of gastric lesions in clinical situation.",
keywords = "Gastric lesion, Gastric mucosal cell, Loxoprofen, Membrane permeabilization",
author = "Naoki Yamakawa and Shintaro Suemasu and Ayumi Kimoto and Yasuhiro Arai and Tomoaki Ishihara and Kazumi Yokomizo and Yoshinari Okamoto and Masami Otsuka and Tanaka, {Ken Ichiro} and Tohru Mizushima",
year = "2010",
doi = "10.1248/bpb.33.398",
language = "English",
volume = "33",
pages = "398--403",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "3",

}

TY - JOUR

T1 - Low direct cytotoxicity of loxoprofen on gastric mucosal cells

AU - Yamakawa, Naoki

AU - Suemasu, Shintaro

AU - Kimoto, Ayumi

AU - Arai, Yasuhiro

AU - Ishihara, Tomoaki

AU - Yokomizo, Kazumi

AU - Okamoto, Yoshinari

AU - Otsuka, Masami

AU - Tanaka, Ken Ichiro

AU - Mizushima, Tohru

PY - 2010

Y1 - 2010

N2 - Pro-drugs of non-steroidal anti-inflammatory drugs (NSAIDs), such as loxoprofen are widely used for clinical purposes because they are not so harmful to the gastrointestinal mucosa. We recently showed that NSAIDs such as indomethacin and celecoxib have direct cytotoxicity (ability to induce necrosis and apoptosis in gastric mucosal cells) due to their membrane permeabilizing activities, which is involved in NSAID-induced gastric lesions. We show here that under conditions where indomethacin and celecoxib clearly induce necrosis and apoptosis, loxoprofen and its active metabolite loxoprofen-OH, do not have such effects in primary culture of guinea pig gastric mucosal cells. Loxoprofen and loxoprofen-OH induced apoptosis more effectively in cultured human gastric cancer cells than in the primary culture. Loxoprofen and loxoprofen-OH exhibited much lower membrane permeabilizing activities than did indomethacin and celecoxib. We thus consider that the low direct cytotoxicity of loxoprofen observed in vitro is involved in its relative safety on production of gastric lesions in clinical situation.

AB - Pro-drugs of non-steroidal anti-inflammatory drugs (NSAIDs), such as loxoprofen are widely used for clinical purposes because they are not so harmful to the gastrointestinal mucosa. We recently showed that NSAIDs such as indomethacin and celecoxib have direct cytotoxicity (ability to induce necrosis and apoptosis in gastric mucosal cells) due to their membrane permeabilizing activities, which is involved in NSAID-induced gastric lesions. We show here that under conditions where indomethacin and celecoxib clearly induce necrosis and apoptosis, loxoprofen and its active metabolite loxoprofen-OH, do not have such effects in primary culture of guinea pig gastric mucosal cells. Loxoprofen and loxoprofen-OH induced apoptosis more effectively in cultured human gastric cancer cells than in the primary culture. Loxoprofen and loxoprofen-OH exhibited much lower membrane permeabilizing activities than did indomethacin and celecoxib. We thus consider that the low direct cytotoxicity of loxoprofen observed in vitro is involved in its relative safety on production of gastric lesions in clinical situation.

KW - Gastric lesion

KW - Gastric mucosal cell

KW - Loxoprofen

KW - Membrane permeabilization

UR - http://www.scopus.com/inward/record.url?scp=77649211082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649211082&partnerID=8YFLogxK

U2 - 10.1248/bpb.33.398

DO - 10.1248/bpb.33.398

M3 - Article

VL - 33

SP - 398

EP - 403

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 3

ER -